Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › H2020

ELEVATE · Early detection of cervical cancer in hard-to-reach populations of women through portable and point-of-care HPV testing

H2020Status: CLOSED1 January 201931 December 2024EU funding €3,301,990Call H2020-SC1-BHC-2018-2020

Cervical cancer is the 4th most common cancer in women worlThe ELEVATE project sets a multidisciplinary team comprising manufactures and experts from Europe and the Community of Latin American and Caribbean States, to improve the global adequacy and coverage of cervical cancer screening, particularly to specific populations of women that by not being regularly screened (hard-to-reach populations) are at higher-risk to develop cervical cancer. Although Cervical cancer is still the fourth most common cancer in women worldwide, with up to 85% of the burden occurring in developing countries, preventive vaccination against human papillomavirus and early detection of precancer in screening programs has shown to be successful in reducing cancer incidence and mortality.1–3 However, different challenges hamper a global implementation of such programs and are in the base of women’s non-attendance to screening. This highlights the lack of reflection of ethnic, cultural and resource differences from different populations in current cervical cancer screening. In ELEVATE it is proposed to conduct social science investigations to identify hard-to-reach women in Belgium, Brazil, Ecuador and Portugal, to address their barriers to screening and to design strategies to make primary screening more accessible to them, and therefore, contribute to reduce the global burden of cervical cancer. This will be complemented with fundamental and technological research to develop an efficient and marketable test for the combined genomic and proteomic detection of high-risk HPV infections in Belgium and Ecuador. The test will be made portable, low-cost, compatible with self-sampling, point-of-care and generate rapid and easy-to-understand results, without relying on electrical outlets or trained health personnel. Integrant part of the proposal is also to infer and disseminate the societal, economic implications of the developed strategies using a hard-to-reach community-based participatory research.

Consortium · 9 organisations

coordinator

UNIVERSITEIT GENT

BE · €1,500,085

participant

UNIVERSITAT ROVIRA I VIRGILI

ES · €341,803

participant

LABMAN AUTOMATION LIMITED

UK · €395,420

participant

FRAUNHOFER GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG EV

DE · €214,578

participant

MICROLIQUID SL

ES · €170,355

participant

UNIVERSIDAD DE CUENCA

EC · €259,900

participant

UNIVERSIDADE NOVA DE LISBOA

PT · €419,850

participant

CONSORCIO DE INVESTIGACION SOBRE VIH SIDA TB CISIDAT

MX

participant

FUNDACAO PIO XII

BR

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.